Foghorn Therapeutics Inc. Restricted Cash, Current
Foghorn Therapeutics Inc. (FHTX) had Restricted Cash, Current of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-06
- 2026-06-30: Restricted Cash, Current $0.00.
- 2026-03-31: Restricted Cash, Current $1.25M.
- 2025-12-31: Restricted Cash, Current $1.25M.
- 2025-09-30: Restricted Cash, Current $1.25M.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.25M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.25M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.25M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.25M 10-Q · filed 2025-08-05 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-11 |
| 2022-09-30 | $25.00K 10-Q · filed 2022-11-08 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-08 |
| 2020-09-30 | $541.00K 10-Q · filed 2020-12-04 |
| 2019-12-31 | $541.00K 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |